When Diana Levine went to the hospital in April 2000 seeking relief for a severe migraine headache, the professional musician and children's record producer never imagined that faulty drug labeling would result in the amputation of her arm. Today she is at the center of a closely-watched Supreme Court case and a national debate about the federal courts and corporate accountability.
